References
- Besnard J , JonesPS, HopkinsAL, PanniferAD. The joint European compound library: boosting precompetitive research. Drug Discov. Today20 (2), 181–186 (2015).
- Minton AP . Models for excluded volume interaction between an unfolded protein and rigid macromolecular cosolutes: Macromolecular crowding and protein stability revisited. Biophys. J.88 (2), 971–985 (2005).
- Kogej T , BlombergN, GreasleyPJet al. Big pharma screening collections: more of the same or unique libraries? The astrazeneca-bayer pharma ag case. Drug Discov. Today18 (19–20), 1014–1024 (2013).
- Schultz Kirkegaard H , ValentinF. Academic drug discovery centres: the economic and organisational sustainability of an emerging model. Drug Discov. Today19 (11), 1699–1710 (2014).
- James LI , FryeSV. Targeting chromatin readers. Clin. Pharmacol. Ther.93 (4), 312–314 (2013).
- Goldberg FW , KettleJG, KogejT, PerryMW, TomkinsonNP. Designing novel building blocks is an overlooked strategy to improve compound quality. Drug Discov. Today20 (1), 11–17 (2015).
- Lovering F , BikkerJ, HumbletC. Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem.52 (21), 6752–6756 (2009).
- Di Capua R , BarraM, SantoroFet al. Towards the realization of label-free biosensors through impedance spectroscopy integrated with ides technology. Eur. Biophys. J.41 (2), 249–256 (2012).
- Sleebs BE , KerstenWJ, KulasegaramSet al. Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-xl. J. Med. Chem.56 (13), 5514–5540 (2013).
- Tao ZF , HasvoldL, WangLet al. Discovery of a potent and selective BCL-XL inhibitor with in vivo activity. ACS Med. Chem. Lett.5 (10), 1088–1093 (2014).
- Terrett N . Drugs in middle space. MedChemComm4 (3), 474 (2013).
- Van Delft MF , WeiAH, MasonKDet al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if mcl-1 is neutralized. Cancer Cell10 (5), 389–399 (2006).
- Clark PG , VieiraLC, TallantCet al. Lp99: discovery and synthesis of the first selective brd7/9 bromodomain inhibitor. Angew. Chem. Int. Ed. Engl.54 (21), 6217–6221 (2015).
- Naud S , WestwoodIM, FaisalAet al. Structure-based design of orally bioavailable 1h-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). J. Med. Chem.56 (24), 10045–10065 (2013).
- Liu X , WilckenR, JoergerACet al. Small molecule induced reactivation of mutant p53 in cancer cells. Nucleic Acids Res.41 (12), 6034–6044 (2013).
- Newman DJ , CraggGM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod.75 (3), 311–335 (2012).
- Jeong Y-C , AnwarM, BikadiZ, HazaiE, MoloneyMG. Natural product inspired antibacterial tetramic acid libraries with dual enzyme inhibition. Chem. Sci.4 (3), 1008–1015 (2013).
- Dahlin JL , WaltersMA. The essential roles of chemistry in high-throughput screening triage. Future Med. Chem.6 (11), 1265–1290 (2014).